Lineage Cell Therapeutics
LCTX
#8509
Rank
C$0.36 B
Marketcap
C$1.45
Share price
-3.74%
Change (1 day)
-7.87%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -C$31.52 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$14.77 Million. In 2025 the company made an earning of -C$30.7 Million a decrease over its 2024 earnings that were of -C$30.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$31.52 Million2.69%
2025 -C$30.7 Million1.4%
2024 -C$30.27 Million-13.16%
2023 -C$34.86 Million9.83%
2022 -C$31.74 Million-54.24%
2021 -C$69.35 Million86.07%
2020 -C$37.27 Million-31.97%
2019 -C$54.79 Million-5.42%
2018 -C$57.93 Million1.1%
2017 -C$57.3 Million-31.06%
2016 -C$83.1 Million-10.38%
2015 -C$92.73 Million29.69%
2014 -C$71.51 Million31.68%
2013 -C$54.31 Million
2011 -C$26.36 Million89.78%
2010 -C$13.89 Million206.06%
2009 -C$4.54 Million-0.58%
2008 -C$4.57 Million164.89%
2007 -C$1.73 Million-30.22%
2006 -C$2.47 Million
2002 -C$2.87 Million-41.04%
2001 -C$4.87 Million-32.04%
2000 -C$7.16 Million-11.85%
1999 -C$8.12 Million
1997 -C$5.22 Million12.12%
1996 -C$4.66 Million106.25%
1995 -C$2.26 Million-11.11%
1994 -C$2.54 Million50%
1993 -C$1.7 Million20%
1992 -C$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.22 Billion 555.55%๐Ÿ‡บ๐Ÿ‡ธ USA